Home
About
Overview
Sharing Data
ORCID
Help
History (31)
Contribution of Ser386 and Ser396 to activation of interferon regulatory factor 3.
Maternal Cardiovascular Health and Adverse Childbirth Outcomes in the United States: Analysis of the Pregnancy Risk Assessment Monitoring System.
The disappearing Barr body in breast and ovarian cancers.
Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors.
Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus.
See All 31 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus.
Khalaf N, Nguyen T, Ramsey D, El-Serag HB. Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus. Clin Gastroenterol Hepatol. 2014 Nov; 12(11):1832-9.e6.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Anti-Inflammatory Agents, Non-Steroidal
Barrett Esophagus
Case-Control Studies
Female
Humans
Male
Middle Aged
Risk Assessment
authors with profiles
David J Ramsey MD, PhD, MPH